CARDINAL HEALTH INC Earnings Per Share Disclosure
| (in millions, except per share amounts) | 2025 | 2024 | 2023 | ||||||||||||||
Net earnings | $ | 1,569 | $ | 853 | $ | 331 | |||||||||||
| Net earnings attributable to noncontrolling interest | (8) | (1) | (1) | ||||||||||||||
Net earnings attributable to Cardinal Health, Inc. | $ | 1,561 | $ | 852 | $ | 330 | |||||||||||
| Weighted-average common shares–basic | 241 | 245 | 261 | ||||||||||||||
| Effect of dilutive securities: | |||||||||||||||||
Employee stock options, restricted share units, and performance share units | 1 | 2 | 1 | ||||||||||||||
| Weighted-average common shares–diluted | 242 | 247 | 262 | ||||||||||||||
Basic earnings per common share attributable to Cardinal Health, Inc.: | $ | 6.48 | $ | 3.48 | $ | 1.27 | |||||||||||
Diluted earnings per common share attributable to Cardinal Health, Inc.: | 6.45 | 3.45 | 1.26 | ||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Aug 12, 2025 | Showing above |
| 2024 | Aug 14, 2024 | |
| 2023 | Aug 15, 2023 | |
| 2022 | Aug 11, 2022 | |
| 2021 | Aug 16, 2021 | |
| 2020 | Aug 13, 2020 | |
| 2019 | Aug 20, 2019 | |
| 2018 | Aug 22, 2018 | |
| 2017 | Aug 10, 2017 | |
| 2016 | Aug 12, 2016 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.